A novel triple receptor agonist conferred weight loss of up to 28.7% at 68 weeks and reductions in pain for adults with overweight or obesity and knee osteoarthritis, according to topline results from ...
Published results showed a combination of home exercise and physical therapy did not result in greater pain reduction ...
ZME Science on MSN
Obesity Patients Lost Nearly 30 percent of Their Body Weight on a New Experimental Drug and Many Saw Their Knee Pain Disappear
In a new clinical trial, people with obesity and knee osteoarthritis who took an experimental drug from Eli Lilly lost large ...
Ampio Pharmaceuticals, Inc., a biopharmaceutical company focused on the advancement of immunomodulatory therapies for common inflammatory conditions, today announced positive data from the modified ...
OAKLAND, Calif.--(BUSINESS WIRE)--OrthoTrophix, Inc. (www.orthotrophix.com), a privately-held biopharmaceutical company, announced today new results from a Phase 2 study of the osteoarthritis drug TPX ...
Genicular Artery Embolization (GAE) represents a new paradigm in treating knee osteoarthritis that had hitherto been handled ...
San Francisco-based Hinge Health has completed a randomized control trial of its digital care program for chronic knee pain. Results were promising, with users of the digital platform outperforming ...
Nes-Ziona, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. ( Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced positive ...
Bundled payment program achieved a 22 percent reduction in hospital readmissions and 17 percent fewer complications for people undergoing knee- and hip-replacement surgeries Total savings for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback